Modern treatments

Microdosing for mental health: What the science says

Published April 5, 2026 · 7 min read · Updated April 2026

Reviewed for accuracy by licensed clinical professionals.

Microdosing involves taking sub-perceptual doses (typically 1/10 to 1/20 of a full dose) of psychedelics like psilocybin or LSD every few days, purportedly improving mood, creativity, and focus.

What research shows

Controlled trials have produced mixed results. Some studies show improvements in mood and well-being, while others suggest significant placebo effects. The largest controlled trial found no significant difference between microdosing and placebo on primary outcomes, though expectancy effects were strong.

The placebo problem

Microdosing research is complicated by strong placebo effects. People who believe they are microdosing report improvements regardless of whether they received an active substance. This does not mean microdosing is ineffective, but it makes determining true effects difficult.

Legal and safety considerations

Psilocybin and LSD are Schedule I federally. Microdosing with illicit substances carries legal risk and quality control concerns (unknown potency and purity). Clinical microdosing research is ongoing but not yet available as a treatment.

Authoritative sources

This article references guidelines from: NIH · NAMI · APA

Frequently asked questions

Does microdosing actually work?

Research is mixed. Some studies show mood improvements, but strong placebo effects make it difficult to determine true efficacy.

Is microdosing safe?

Short-term safety data is limited. Long-term effects of regular sub-perceptual psychedelic use are unknown.

Is microdosing legal?

No. Psilocybin and LSD remain Schedule I federally. Microdosing with illicit substances carries legal and quality risks.

Disclaimer: Informational only. Not medical advice. SAMHSA: 1-800-662-4357.